Author and cultural historian Mike Jay discussed the role of psychedelics as a bridge between science and spirituality at a Monday webinar hosted by the Harvard Divinity School’s Center for the Study of World Religions.
Author Michael K. Pollan, a Harvard lecturer in English and professor of the practice in non-fiction, spoke about the future of research into the societal and cultural aspects of psychedelics during a Mahindra Humanities Center talk on Wednesday.
Dean of the College Harry R. Lewis ’68 and Dean of Students Archie C. Epps III released a 16-clause statement outlining a strengthened alcohol policy on Oct. 22, 1997, leading to radical changes to Harvard’s alcohol and smoking rules in the late 1990s.
The Project on Psychedelics Law and Regulation at Harvard Law School’s Petrie-Flom Center hosted a virtual panel on psychedelics in Australia, Canada, the Netherlands, and the United Kingdom on Monday.
A panel of legal experts discussed lessons the psychedelics industry can learn from the history of U.S. cannabis policy during a virtual event hosted by Harvard Law School’s Petrie-Flom Center.
A Boston man was sentenced on Oct. 5 to 10 years in prison for conspiring to distribute fentanyl, heroin, and cocaine — some of which was delivered to a Harvard biology lab.
Harvard researchers at Massachusetts General Hospital found that lamivudine, a commonly used drug for HIV treatment, showed promise in combating metastatic colorectal cancer.
Legal and Medical Experts Discuss Alternative Approaches for Aiding Families Struggling With Substance Abuse
Legal and medical experts discussed how to support families struggling with substance abuse in a Tuesday virtual panel jointly hosted by Massachusetts General Hospital's Center for Law, Brain, and Behavior and Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.
Psychedelics reform advocates discussed decriminalizing drugs, reducing stigma, and centering Indigenous voices in a Harvard Law School webinar on Wednesday.
Massachusetts General Hospital, an affiliate of Harvard Medical School, has launched a new center to study the clinical benefits of psychedelics in treating mental illness.
Massachusetts State Rep. Michael L. Connolly, a Democrat who represents parts of Cambridge and Somerville, submitted two bills in the Massachusetts House last month aimed at reforming controlled substance laws.
Panelists advocated for the decriminalization of psychedelics to an audience of more than 200 people during a Wednesday webinar hosted by Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.
More than 30 students, faculty, and members of the public gathered at Harvard’s Arthur M. Sackler Museum Friday to commemorate a new art installation honoring those affected by the opioid epidemic.
Harvard Square smoke shops are facing steep commercial consequences following the implementation of a newly announced ban on the sale of vaping products in Massachusetts late last month.
The council voted 7-0 in favor of the “Cannabis Business Permitting Ordinance,” with Councilors E. Denise Simmons and Timothy J. Toomey, Jr. abstaining.
The Cambridge City Council took the first step to pass an amendment to its surveillance ordinance to ban the use of facial recognition city-wide during its annual summer meeting Tuesday.
Officers from the Cambridge Police Department responded to reports of a fatal overdose on the front steps of Blue Bottle Coffee in Harvard Square at approximately 7 a.m. Wednesday morning.
In recent months, dozens of mothers whose children died from opioid overdoses wrote letters to Bacow urging him to cut ties with the Sacklers and refuse future funding from them.
The donation, given by Charles R. Broderick, is the largest independent donation ever made to fund biological study of cannabinoids on the brain and behavior.
Administrators from the Office of Alcohol and Other Drug Services have launched a campaign to raise awareness around drugs and alcohol on Harvard’s campus through Instagram and Facebook posts and signs around campus.
Harvard University Health Services Director Paul J. Barreira raised concerns about the logistics of expanding access on campus to naloxone, a drug used to reverse the symptoms of opioid overdose.